A multimodal approach to managing the symptoms of multiple sclerosis

被引:90
作者
Crayton, H
Heyman, RA
Rossman, HS
机构
[1] Georgetown Univ Hosp, Multiple Sclerosis Ctr, Washington, DC 20007 USA
[2] Univ Pittsburgh, Sch Med, Multiple Sclerosis Ctr, Pittsburgh, PA USA
[3] Michigan Inst Neurol Disorders, Multiple Sclerosis Ctr, Farmington Hills, MI USA
关键词
D O I
10.1212/WNL.63.11_suppl_5.S12
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is a disease of the CNS with a challenging clinical course characterized by heterogeneous symptoms related to inflammation and demyelination. Disease-modifying agents (DMAs) are used to treat the related neuronal degradation. Certain symptoms occur regularly, although with variable frequency, regardless of treatment with DMAs. Because there is no cure for MS at this time, symptom management is critically important to quality of life. Symptoms commonly seen are spasticity, fatigue, sexual dysfunction, bladder dysfunction, pain, and cognitive dysfunction. Other symptoms include depression, bowel dysfunction, paroxysmal symptoms, and weakness. The symptom management model that provides optimal results for patients with MS is a multimodal approach using effective communication, patient education, physical modalities and activities, occupational and other therapies, and pharmacologic interventions. Individualizing treatment for each patient involves gaining control of symptoms as early as possible to prevent cycles of symptoms from developing.
引用
收藏
页码:S12 / S18
页数:7
相关论文
共 83 条
  • [21] 2-1
  • [22] FOSTER HE, 2002, MSQR, V21
  • [23] EFFECT OF DANTROLENE SODIUM ON SPASTICITY IN MULTIPLE-SCLEROSIS
    GELENBERG, AJ
    POSKANZER, DC
    [J]. NEUROLOGY, 1973, 23 (12) : 1313 - 1315
  • [24] VERAPAMIL-INDUCED CHANGES IN CENTRAL CONDUCTION IN PATIENTS WITH MULTIPLE-SCLEROSIS
    GILMORE, RL
    KASARSKIS, EJ
    MCALLISTER, RG
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (11) : 1140 - 1146
  • [25] A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments
    Greene, YM
    Tariot, PN
    Wishart, H
    Cox, C
    Holt, CJ
    Schwid, S
    Noviasky, J
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (03) : 350 - 356
  • [26] LHERMITTES SIGN - FROM OBSERVATION TO EPONYM
    GUTRECHT, JA
    [J]. ARCHIVES OF NEUROLOGY, 1989, 46 (05) : 557 - 558
  • [27] Urinary, faecal and sexual dysfunction in patients with multiple sclerosis
    Hennessey, A
    Robertson, NP
    Swingler, R
    Compston, DAS
    [J]. JOURNAL OF NEUROLOGY, 1999, 246 (11) : 1027 - 1032
  • [28] PREVALENCE OF BOWEL DYSFUNCTION IN MULTIPLE-SCLEROSIS - A POPULATION SURVEY
    HINDS, JP
    EIDELMAN, BH
    WALD, A
    [J]. GASTROENTEROLOGY, 1990, 98 (06) : 1538 - 1542
  • [29] TRIGEMINAL NEURALGIA IN MULTIPLE-SCLEROSIS
    HOOGE, JP
    REDEKOP, WK
    [J]. NEUROLOGY, 1995, 45 (07) : 1294 - 1296
  • [30] MOOD DISORDER AND MULTIPLE-SCLEROSIS
    JOFFE, RT
    LIPPERT, GP
    GRAY, TA
    SAWA, G
    HORVATH, Z
    [J]. ARCHIVES OF NEUROLOGY, 1987, 44 (04) : 376 - 378